Stem cell-derived organoids have emerged as transformative tools for disease modeling and drug development, yet their potential is often hampered by variability and reproducibility challenges.
This article synthesizes current research and emerging strategies to overcome the central challenge in regenerative medicine: the poor survival and engraftment of transplanted stem cells.
This article addresses the critical challenge of variability in differentiation efficiency across patient-specific stem cell lines, a major bottleneck in regenerative medicine and drug development.
The profound therapeutic potential of induced pluripotent stem cells (iPSCs) is tempered by the significant challenge of genomic instability, which can compromise experimental results and pose serious risks in clinical...
This article provides a comprehensive guide for researchers and drug development professionals on optimizing cryopreservation and thawing processes for personalized stem cell therapies.
Allogeneic stem cell transplantation holds transformative potential for treating hematologic cancers and genetic disorders, but immune rejection remains a significant barrier to its broad application.
This article provides a comprehensive analysis of current strategies and emerging technologies for mitigating teratoma formation risk in human pluripotent stem cell (hPSC)-derived therapies.
This article provides a comprehensive overview of the latest strategies in tissue engineering that combine stem cells with advanced biomaterial scaffolds.
Single-cell RNA sequencing (scRNA-seq) is revolutionizing the characterization of patient-derived stem cell lines by providing unprecedented resolution of cellular heterogeneity, dynamic transitions, and drug response mechanisms.
This article provides a comprehensive guide to Good Manufacturing Practice (GMP) compliance for researchers and drug development professionals navigating the complex transition from laboratory research to clinical manufacturing of patient-specific...